Boston Scientific Warning Letter Cites LP Stent Study Protocol Failures
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific stent trial protocol violations cited in a recent FDA warning letter pertain to the now obsolete LP Stent and are unrelated to any other products, according to the company